1. Home
  2. ANIP vs ELME Comparison

ANIP vs ELME Comparison

Compare ANIP & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • ELME
  • Stock Information
  • Founded
  • ANIP 2001
  • ELME 1960
  • Country
  • ANIP United States
  • ELME United States
  • Employees
  • ANIP N/A
  • ELME N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • ELME Real Estate Investment Trusts
  • Sector
  • ANIP Health Care
  • ELME Real Estate
  • Exchange
  • ANIP Nasdaq
  • ELME Nasdaq
  • Market Cap
  • ANIP 1.4B
  • ELME 1.4B
  • IPO Year
  • ANIP N/A
  • ELME N/A
  • Fundamental
  • Price
  • ANIP $64.03
  • ELME $15.37
  • Analyst Decision
  • ANIP Strong Buy
  • ELME Hold
  • Analyst Count
  • ANIP 9
  • ELME 5
  • Target Price
  • ANIP $80.56
  • ELME $18.25
  • AVG Volume (30 Days)
  • ANIP 303.6K
  • ELME 596.9K
  • Earning Date
  • ANIP 08-05-2025
  • ELME 08-05-2025
  • Dividend Yield
  • ANIP N/A
  • ELME 4.55%
  • EPS Growth
  • ANIP N/A
  • ELME N/A
  • EPS
  • ANIP N/A
  • ELME N/A
  • Revenue
  • ANIP $674,068,000.00
  • ELME $243,915,000.00
  • Revenue This Year
  • ANIP $30.84
  • ELME $4.84
  • Revenue Next Year
  • ANIP $7.39
  • ELME $0.80
  • P/E Ratio
  • ANIP N/A
  • ELME N/A
  • Revenue Growth
  • ANIP 30.27
  • ELME 5.31
  • 52 Week Low
  • ANIP $52.50
  • ELME $13.95
  • 52 Week High
  • ANIP $77.00
  • ELME $18.49
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 44.50
  • ELME 34.38
  • Support Level
  • ANIP $65.68
  • ELME $15.62
  • Resistance Level
  • ANIP $68.18
  • ELME $16.35
  • Average True Range (ATR)
  • ANIP 2.29
  • ELME 0.32
  • MACD
  • ANIP -0.27
  • ELME -0.09
  • Stochastic Oscillator
  • ANIP 13.00
  • ELME 6.64

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

Share on Social Networks: